Idiopathische Lungenfibrose: Best Practices für das Monitoring und Management einer unerbittlichen fibrosierenden Erkrankung

a Department of Respiratory Diseases, Unit for Interstitial Lung Diseases, University Hospitals Leuven, Leuven, Belgien; b Department of Respiratory Medicine, Erasmus MC, University Medical Centre, Rotterdam, Niederlande; c Department of Pneumology, Hôpital Erasme, Université libre de Bruxelles, Brüssel, Belgien; d First Academic Department of Pneumonology, Interstitial Lung Diseases Unit, Department of Medicine, National and Kapodistrian University of Athens, Athen, Griechenland; e Department of Respiratory Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, Niederlande; f Department of Pneumology, Coimbra University Hospital, Coimbra, Portugal; g Department of Respiratory Medicine and Allergology, Aarhus University Hospital, Aarhus, Dänemark; h Department of Internal Medicine/Respiratory Medicine and Allergology, Institute of Medicine, University of Gothenburg, Göteborg, Schweden; i 2nd Pulmonary Medicine Department, General University Hospital «Attikon», Medical School, National and Kapodistrian University of Athens, Athen, Griechenland; j Department of Pulmonology, Hospital de São João, Porto, Portugal; k Herlev and Gentofte University Hospital, Kopenhagen, Dänemark; l Department of Pulmonology ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, Niederlande; m Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Dänemark